TrialOral oncology2009

Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.

Ezra Eddy Wyssam Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.